(Q81662285)
Statements
High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy (English)
Frank V Fossella
Joe Y Chang
Ritsuko Komaki
Ryohei Sasaki
Zhongxing Liao
Craig W Stevens
Charles Lu
Pamela K Allen
James D Cox
Margaret R Spitz